Please fill out the form below to get started and we’ll be in touch within 24 hours with next steps.
Call Us for Immediate Assistance (347) 691-3494
Revlimid affects the immune system. It promotes immune responses to help slow tumor growth.
Revlimid is used to treat multiple myeloma (bone marrow cancer), either in combination with another medicine or after stem cell transplant.
Revlimid is also used to treat anemia (a lack of red blood cells) in patients with myelodysplastic syndrome caused by an abnormal chromosome. This disorder is also called deletion 5q MDS, because part of chromosome 5 is missing. In people with this disorder, the bone marrow does not produce enough healthy blood cells.
Revlimid is also used to treat mantle cell lymphoma (a rare cancer of the lymph nodes), after other medications have been tried without success.
Revlimid should not be used for chronic lymphocytic leukemia (CLL) unless you are in a controlled medical study. Lenalidomide can increase the risk of death from serious heart problems in people with CLL.
This medicine is available only from a certified pharmacy under a special program called Revlimid REMS. Your doctor must be registered in the program in order to prescribe lenalidomide for you. You must be registered in the program and sign documents stating that you understand the dangers of this medication and that you agree to use birth control measures as required by the program.
Never use Revlimid if you are pregnant. Even one dose of lenalidomide can cause severe, life-threatening birth defects or death of a baby if the mother or the father is taking this medicine at the time of conception or during pregnancy.
Use birth control to prevent pregnancy, whether you are a man or a woman. For women: Use two forms of birth control beginning 4 weeks before you start taking Revlimid and ending 4 weeks after you stop taking it. For men: Use a condom to prevent pregnancy during your treatment, and for up to 4 weeks after your treatment ends.
Revlimid may cause blood clots. Stop using this medicine and call your doctor at once if you have symptoms such as sudden numbness, severe headache, problems with vision or speech, chest pain, shortness of breath, coughing up blood, or swelling in your arm or leg.
Revlimid can lower blood cells that help your body fight infections and help your blood to clot. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches). You will need frequent blood tests while you are taking Revlimid.
You should not use Revlimid if you are allergic to lenalidomide.
Revlimid can cause severe, life-threatening birth defects or death of a baby if the mother or the father is taking this medicine at the time of conception or during pregnancy. Even one dose of lenalidomide can cause major birth defects of the baby’s arms and legs, bones, ears, eyes, face, and heart. Never use Revlimid if you are pregnant. Tell your doctor right away if your period is late while taking Revlimid.
For Women: If you have not had a hysterectomy, you will be required to use two reliable forms of birth control beginning 4 weeks before you start taking Revlimid and ending 4 weeks after you stop taking it. Even women with fertility problems are required to use birth control while taking this medicine. You must also have a negative pregnancy test at 10 to 14 days before treatment and again at 24 hours before. While you are taking Revlimid, you will have a pregnancy test every 2 to 4 weeks.
The birth control method you use must be proven highly effective, such as birth control pills, an intrauterine device (IUD), a tubal ligation, or a sexual partner’s vasectomy. The extra form of birth control you use must be a barrier method such as a latex condom, a diaphragm, or a cervical cap.
Stop using Revlimid and call your doctor at once if you quit using birth control, if your period is late, or if you think you might be pregnant. Not having sexual intercourse (abstinence) is the most effective method of preventing pregnancy.
For Men: If a man fathers a baby while using Revlimid, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment, and for up to 4 weeks after your treatment ends. You must agree in writing to always use latex condoms when having sex with a woman who is able to get pregnant, even if you have had a vasectomy. Contact your doctor if you have had unprotected sex, even once, or if you think your female sexual partner may be pregnant.
To make sure Revlimid is safe for you, tell your doctor if you have ever had:
Using Revlimid may increase your risk of developing other types of cancer, such as leukemia or lymphoma. Talk with your doctor about your specific risk.
You should not breast-feed while using Revlimid.
Take Revlimid exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended. Never share this medicine with another person, even if they have the same disorder you have.
Take the medicine at the same time each day. You may take Revlimid with or without food.
Take each dose with a full glass of water. Swallow the capsule whole, without breaking it open.
Lenalidomide can increase your risk of bleeding or infection. Your blood will need to be tested often.
The medicine from an open capsule can be dangerous if it gets on your skin. If this occurs, wash your skin with soap and water. Ask your doctor or pharmacist how to safely handle and dispose of a broken capsule.
Store Revlimid at room temperature away from moisture and heat.
Usual Adult Dose for Multiple Myeloma:
In combination with dexamethasone:
25 mg orally once a day on Days 1 to 21 of repeated 28-day cycles until disease progression or unacceptable toxicity
Maintenance therapy following auto-HSCT:
10 mg once a day continuously (Days 1 to 28 of repeated 28-day cycles) for 3 cycles, then increase to 15 mg once a day if tolerated until disease progression or unacceptable toxicity
-For patients who are not eligible for auto-HSCT, therapy should continue until disease progression or unacceptable toxicity.
-For patients who are eligible for auto-HSCT, hematopoietic stem cell mobilization should occur within 4 cycles.
-Following auto-HSCT, initiate maintenance therapy after adequate hematologic recovery (ANC 1000/mcL or more AND/OR platelet count 75,000/mcL or more).
-Consult the manufacturer product information for dexamethasone dosing recommendations.
-In combination with dexamethasone for multiple myeloma (MM)
-Maintenance therapy in patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT)
Usual Adult Dose for Myelodysplastic Disease:
10 mg orally once a day; therapy is continued or modified based upon clinical and laboratory findings until disease progression or unacceptable toxicity
Use: Treatment of transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities
Usual Adult Dose for Lymphoma:
FOLLICULAR LYMPHOMA OR MARGINAL ZONE LYMPHOMA:
20 mg orally once a day on Days 1 through 21 of repeated 28-day cycles for up to 12 cycles in combination with a rituximab-product
MANTLE CELL LYMPHOMA:
25 mg orally once a day on Days 1 to 21 of repeated 28-day cycles until disease progression or unacceptable toxicity; treatment is continued, modified, or discontinued based upon clinical and laboratory findings
-For the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after 2 prior therapies, onw1 of which included bortezomib
Use: In combination with a rituximab product for the treatment of previously treated follicular lymphoma (FL)
-In combination with a rituximab product for the treatment of previously treated marginal zone lymphoma (MZL)
Take the missed dose as soon as you remember. If you are more than 12 hours late, skip the missed dose. Do not take extra medicine to make up the missed dose.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
You must not donate blood or sperm while you are using Revlimid, and for at least 4 weeks after your last dose. Avoid exposing another person to your blood or semen through casual or sexual contact.
This medicine can pass into body fluids (urine, feces, vomit). Caregivers should wear rubber gloves while cleaning up a patient’s body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.
Get emergency medical help if you have signs of an allergic reaction to Revlimid: (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).
Call your doctor at once if you have:
Common Revlimid side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
ell your doctor if you also use pembrolizumab (Keytruda).
If you use hormonal birth control (pills, implants, injections) to prevent pregnancy: There are certain drugs that can make hormonal birth control less effective in your body. Tell your doctor about all other medicines you use. You may need to replace your hormonal birth control method with another effective form of contraception.
Other drugs may interact with lenalidomide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Revlimid does not usually cause weight gain, in fact, 7% to 20% of people in clinical trials report losing weight while taking Revlimid, but RAPID weight gain may be a sign of a serious side effect such as fluid retention or tumor lysis syndrome, and you should call your doctor immediately.
Symptoms of fluid retention include swelling in the feet, ankles, or face and rapid weight gain. Some people may also feel short of breath if fluid has built up in their lungs. Notify your healthcare team if you have any swelling, unexpected weight gain, or shortness of breath.
Tumor Lysis Syndrome (TLS) is a life-threatening condition that occurs when a large number of cancer cells die within a short period, releasing their contents into the blood. Symptoms of TLS include pain in the joints, back, side, or stomach; swelling of the feet or lower legs; a decrease in the amount of urine; a rapid weight gain, or unusual tiredness or weakness. Call your doctor right away if you have any of these symptoms.
Revlimid may be taken at any time of the day, so long as it is taken consistently at the same time each day. Some people suggest taking it at night if it makes you sleepy or in the morning if it keeps you awake. But the most important thing is to take it at a time you won’t forget.
Revlimid capsules should be swallowed whole with a glass of water and may be taken with or without food. Do not open, break, or chew your capsules and do not handle them any more than needed. If you touch a broken Revlimid capsule or the medicine in the capsule, wash the area of your body with soap and water
If you miss a dose of REVLIMID and it has been less than 12 hours since your regular time, take it as soon as you remember. If it has been more than 12 hours, skip your missed dose. Do not take 2 doses at the same time.
Theoretically, Revlimid stays in your system for 15 to 25 hours (just over 1 day). This is based on the average half-life of Revlimid which is 3 hours in healthy people and 3 to 5 hours in people with multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. A half-life is the time it takes for 50% of a drug to leave a person’s body, and experts estimate it takes 4 to 5 half-lives for a drug to be completely removed from the body, which calculates out to 15 to 25 hours. One study that tagged Revlimid with a radioactive compound showed that 82% of a dose was eliminated within 24 hours, but it took up to 10 days for 90% to be eliminated in the urine, and for 4% to be eliminated in the feces. At least 6% is excreted as the metabolites hydroxy-lenalidomide and N-acetyl-lenalidomide.
How long you take Revlimid for depends on your medical condition, your response to treatment or lab test results, and your tolerance of Revlimid’s side effects. Some trials have followed people for at least 108 months (9 years).
For people with newly diagnosed multiple myeloma not receiving a stem cell transplant, Revlimid 25mg is taken in cycles (once daily for 21 days then stopped for 7 days, then started again for 21 days and so on) in combination with dexamethasone which is taken on 4 days out of every 28 days.
For people who have had a stem cell transplant who have multiple myeloma, Revlimid 10mg is taken every day for 28 days. After three 28-day cycles, the dose may be increased to 15mg once daily.
The active substance in Revlimid, lenalidomide, works by binding to a protein called cereblon (CRBN), which recognizes and targets other key proteins destined for degradation. Revlimid helps your immune system to recognize, target, and destroy certain cancerous cells, such as those found in multiple myeloma, and also helps to prevent new cell growth by starving cancerous cells of blood.
Revlimid is not a chemotherapy drug it is an immune-modulating treatment that helps your immune system to fight cancer.